PIONEERING THE FUTURE OF VACCINATION AND IMMUNE THERAPY
Landmark Vaccines is a next-generation vaccine company dedicated to transforming how infectious diseases and immune disorders are prevented and treated. Our mission is to make immunisation simpler, safer, and more effective - harnessing both proven and emerging vaccine technologies to protect global populations.
AT THE FOREFRONT OF VACCINE TECHNOLOGY
From conventional sub-unit vaccines to cutting-edge nucleic acid–based vaccines and immune therapies, Landmark Vaccines integrates deep scientific expertise with proprietary delivery systems to address some of the world’s most urgent health challenges.
Headquartered at the
Loughborough University Science and Enterprise Park, the company combines advanced formulation science, novel delivery systems, and scalable GMP manufacturing to create vaccines that are not only highly effective but also accessible and deployable globally - without dependence on cold-chain logistics or trained clinical personnel.
